Spotlight
Video

2012 ASCO Skin Cancer Update with Dr. Antoni Ribas, MD of University of California Los Angeles talks about PD-L 1 and Anti PD-L1, Pelitinib, Dabrafenib, Vemurafenib, Brim 3 trial, Braf inhibitors, and Mek inhibitors

imedex has 1073 videos Subscribe Here

Loading........
Description: 2012 ASCO Skin Cancer Update with Dr. Antoni Ribas, MD of University of California Los Angeles talks about PD-L 1 and Anti PD-L1, Pelitinib, Dabrafenib, Vemurafenib, Brim 3 trial, Braf inhibitors, and Mek inhibitors. In addition, he discusses ASCO Abstract 8500, Abstract 8501, Abstract 8502, Abstract 8503 and Abstract 8507.
Shared By : imedex
Posted on : 06/04/12
Added : 5 years ago